Princen HM - Search Results

1

No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study.

Tsikas D, Pham VV, Suchy MT, van de Ree MA, Huisman MV, Frölich JC, Princen HM; DALI-Study Group. Tsikas D, et al. Among authors: princen hm. Pharmacol Res. 2015 Apr;94:1-8. doi: 10.1016/j.phrs.2015.01.004. Epub 2015 Feb 7. Pharmacol Res. 2015. PMID: 25662039 Clinical Trial.

2

Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.

de Man FH, Jonkers IJ, Schwedhelm E, Smelt AH, Onkenhout W, van Duyvenvoorde W, Buytenhek R, Leuven JA, Troost R, van Der Laarse A, Princen HM. de Man FH, et al. Among authors: princen hm. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2434-40. doi: 10.1161/01.atv.20.11.2434. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073849 Clinical Trial.

3

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus.

van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C; DALI-Study Group. van de Ree MA, et al. Among authors: princen hm. Atherosclerosis. 2003 Jan;166(1):129-35. doi: 10.1016/s0021-9150(02)00316-7. Atherosclerosis. 2003. PMID: 12482559 Clinical Trial.

4

Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus.

Van De Ree MA, De Maat MP, Kluft C, Meinders AE, Princen HM, Huisman MV; DALI Study Group. Van De Ree MA, et al. Among authors: princen hm. J Thromb Haemost. 2003 Aug;1(8):1753-7. doi: 10.1046/j.1538-7836.2003.00357.x. J Thromb Haemost. 2003. PMID: 12911589 Free article. Clinical Trial.

5

The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.

Alizadeh Dehnavi R, Beishuizen ED, van de Ree MA, Le Cessie S, Huisman MV, Kluft C, Princen HM, Tamsma JT. Alizadeh Dehnavi R, et al. Among authors: princen hm. Eur J Intern Med. 2008 Mar;19(2):115-21. doi: 10.1016/j.ejim.2007.06.011. Epub 2007 Nov 5. Eur J Intern Med. 2008. PMID: 18249307

6

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.

Berbée JF, Wong MC, Wang Y, van der Hoorn JW, Khedoe PP, van Klinken JB, Mol IM, Hiemstra PS, Tsikas D, Romijn JA, Havekes LM, Princen HM, Rensen PC. Berbée JF, et al. Among authors: princen hm. J Nutr Biochem. 2013 Aug;24(8):1423-30. doi: 10.1016/j.jnutbio.2012.11.009. Epub 2013 Jan 18. J Nutr Biochem. 2013. PMID: 23337345

7

Results, meta-analysis and a first evaluation of U_NOxR, the urinary nitrate-to-nitrite molar ratio, as a measure of nitrite reabsorption in experimental and clinical settings.

Tsikas D, Hanff E, Bollenbach A, Kruger R, Pham VV, Chobanyan-Jürgens K, Wedekind D, Arndt T, Jörns A, Berbée JFP, Princen HMG, Lücke T, Mariotti F, Huneau JF, Ückert S, Frölich JC, Lenzen S. Tsikas D, et al. Amino Acids. 2018 Jul;50(7):799-821. doi: 10.1007/s00726-018-2573-z. Epub 2018 May 4. Amino Acids. 2018. PMID: 29728915 Free article.

8

Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus.

Brussaard HE, Gevers Leuven JA, Kluft C, Krans HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, Princen HM. Brussaard HE, et al. Among authors: princen hm. Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):324-30. doi: 10.1161/01.atv.17.2.324. Arterioscler Thromb Vasc Biol. 1997. PMID: 9081688 Clinical Trial.

9

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: princen hm. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

10

Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice.

Trion A, de Maat M, Jukema W, Maas A, Offerman E, Havekes L, Szalai A, van der Laarse A, Princen H, Emeis J. Trion A, et al. J Cardiovasc Pharmacol. 2006 Jan;47(1):89-95. doi: 10.1097/01.fjc.0000195603.65858.27. J Cardiovasc Pharmacol. 2006. PMID: 16424791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters